Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
Abatacept Versus Tocilizumab by Subcutaneous Administration for the Treatment of Rheumatoid Arthritis in TNF Alpha Inhibitor Inadequate Responder Patients: A Randomized, Open-labeled, Superiority Trial AbataceptVersus Tocilizumab by Subcutaneous Administration for the Treatment of Rheumatoid Arthritis ...
Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the PrefilledSyringeStudy to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept125 mg Using the BD Autoi ...
Phase Ib, Multicenter, Randomized, Open-Label, Parallel-Group Study to Characterize the Pharmacokinetics of a Single Dose of Abatacept 125 mg Administered Subcutaneously Using the BD Physioject™ Autoinjector or the UltraSafe Passive Needle Guard PrefilledSyringePhase Ib, Multicenter, Randomized, Open-Label, Parallel-Group Study to Characterize the Pharmacokine ...